In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Differin, Adapalene Drug Master File in Korea (Differin, Adapalene KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Differin, Adapalene. The MFDS reviews the Differin, Adapalene KDMF as part of the drug registration process and uses the information provided in the Differin, Adapalene KDMF to evaluate the safety and efficacy of the drug.
After submitting a Differin, Adapalene KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Differin, Adapalene API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Differin, Adapalene suppliers with KDMF on PharmaCompass.